Report Detail
Global (United States, European Union and China) Cancer Drugs Market Research Report 2019-2025
- RnM3641530 |
- 02 August, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
It is used in the treatment of cancer.
In 2019, the market size of Cancer Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cancer Drugs.
This report studies the global market size of Cancer Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cancer Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bayer
GlaxoSmithKline
Novartis
Sanofi and Pfizer
Amgen
Merck
Bristol-Myers Squibb
Celgene Corporation
Ariad Pharmaceuticals
Eli Lilly
Hoffmann-La Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals
Market Segment by Product Type
Breast Cancer
Blood Cancer
Gastrointestinal Cancer
Prostate Cancer
Skin Cancer
Lung Cancer
Others
Market Segment by Application
Immunotherapy
Targeted Therapy
Chemotherapy
Hormone Therapy
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Cancer Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cancer Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Cancer Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Cancer Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Breast Cancer
- 1.3.3 Blood Cancer
- 1.3.4 Gastrointestinal Cancer
- 1.3.5 Prostate Cancer
- 1.3.6 Skin Cancer
- 1.3.7 Lung Cancer
- 1.3.8 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Cancer Drugs Market Share by Application (2019-2025)
- 1.4.2 Immunotherapy
- 1.4.3 Targeted Therapy
- 1.4.4 Chemotherapy
- 1.4.5 Hormone Therapy
- 1.4.6 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Cancer Drugs Market Size
- 2.1.1 Global Cancer Drugs Revenue 2014-2025
- 2.1.2 Global Cancer Drugs Sales 2014-2025
- 2.2 Cancer Drugs Growth Rate by Regions
- 2.2.1 Global Cancer Drugs Sales by Regions 2014-2019
- 2.2.2 Global Cancer Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Cancer Drugs Sales by Manufacturers
- 3.1.1 Cancer Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Cancer Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Cancer Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Cancer Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Cancer Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Cancer Drugs Price by Manufacturers
- 3.4 Key Manufacturers Cancer Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Cancer Drugs Market
- 3.6 Key Manufacturers Cancer Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Breast Cancer Sales and Revenue (2014-2019)
- 4.1.2 Blood Cancer Sales and Revenue (2014-2019)
- 4.1.3 Gastrointestinal Cancer Sales and Revenue (2014-2019)
- 4.1.4 Prostate Cancer Sales and Revenue (2014-2019)
- 4.1.5 Skin Cancer Sales and Revenue (2014-2019)
- 4.1.6 Lung Cancer Sales and Revenue (2014-2019)
- 4.1.7 Others Sales and Revenue (2014-2019)
- 4.2 Global Cancer Drugs Sales Market Share by Type
- 4.3 Global Cancer Drugs Revenue Market Share by Type
- 4.4 Cancer Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Cancer Drugs Sales by Application
6 United States
- 6.1 United States Cancer Drugs Breakdown Data by Company
- 6.2 United States Cancer Drugs Breakdown Data by Type
- 6.3 United States Cancer Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Cancer Drugs Breakdown Data by Company
- 7.2 European Union Cancer Drugs Breakdown Data by Type
- 7.3 European Union Cancer Drugs Breakdown Data by Application
8 China
- 8.1 China Cancer Drugs Breakdown Data by Company
- 8.2 China Cancer Drugs Breakdown Data by Type
- 8.3 China Cancer Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Cancer Drugs Breakdown Data by Company
- 9.2 Rest of World Cancer Drugs Breakdown Data by Type
- 9.3 Rest of World Cancer Drugs Breakdown Data by Application
- 9.4 Rest of World Cancer Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Cancer Drugs Sales by Countries
- 9.4.2 Rest of World Cancer Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Bayer
- 10.1.1 Bayer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Cancer Drugs
- 10.1.4 Cancer Drugs Product Introduction
- 10.1.5 Bayer Recent Development
- 10.2 GlaxoSmithKline
- 10.2.1 GlaxoSmithKline Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Cancer Drugs
- 10.2.4 Cancer Drugs Product Introduction
- 10.2.5 GlaxoSmithKline Recent Development
- 10.3 Novartis
- 10.3.1 Novartis Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Cancer Drugs
- 10.3.4 Cancer Drugs Product Introduction
- 10.3.5 Novartis Recent Development
- 10.4 Sanofi and Pfizer
- 10.4.1 Sanofi and Pfizer Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Cancer Drugs
- 10.4.4 Cancer Drugs Product Introduction
- 10.4.5 Sanofi and Pfizer Recent Development
- 10.5 Amgen
- 10.5.1 Amgen Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Cancer Drugs
- 10.5.4 Cancer Drugs Product Introduction
- 10.5.5 Amgen Recent Development
- 10.6 Merck
- 10.6.1 Merck Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Cancer Drugs
- 10.6.4 Cancer Drugs Product Introduction
- 10.6.5 Merck Recent Development
- 10.7 Bristol-Myers Squibb
- 10.7.1 Bristol-Myers Squibb Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Cancer Drugs
- 10.7.4 Cancer Drugs Product Introduction
- 10.7.5 Bristol-Myers Squibb Recent Development
- 10.8 Celgene Corporation
- 10.8.1 Celgene Corporation Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Cancer Drugs
- 10.8.4 Cancer Drugs Product Introduction
- 10.8.5 Celgene Corporation Recent Development
- 10.9 Ariad Pharmaceuticals
- 10.9.1 Ariad Pharmaceuticals Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Cancer Drugs
- 10.9.4 Cancer Drugs Product Introduction
- 10.9.5 Ariad Pharmaceuticals Recent Development
- 10.10 Eli Lilly
- 10.10.1 Eli Lilly Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Cancer Drugs
- 10.10.4 Cancer Drugs Product Introduction
- 10.10.5 Eli Lilly Recent Development
- 10.11 Hoffmann-La Roche
- 10.12 Boehringer Ingelheim
- 10.13 Johnson and Johnson
- 10.14 Teva Pharmaceuticals
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Cancer Drugs Sales Channels
- 11.2.2 Cancer Drugs Distributors
- 11.3 Cancer Drugs Customers
12 Market Forecast
- 12.1 Global Cancer Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Cancer Drugs Sales Forecast by Type
- 12.3 Global Cancer Drugs Sales Forecast by Application
- 12.4 Cancer Drugs Forecast by Regions
- 12.4.1 Global Cancer Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Cancer Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Cancer Drugs. Industry analysis & Market Report on Cancer Drugs is a syndicated market report, published as Global (United States, European Union and China) Cancer Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Cancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
